主要代表文章如下：

1.Wang H#, Lu Z#, Li Y, Liu T, Zhao L, Gao T, Lu X, Gao B. Virtual Screening of Novel 24-Dehydroxysterol Reductase (DHCR24) Inhibitors and the Biological Evaluation of Irbesartan in Cholesterol-Lowering Effect.

2.Wang H#, Lu Z#, Yang W, Li X, Gao M, Duan C, Li Y, Lu X and Gao B. A study based on reverse network pharmacology of kidney stones identified that quercetin targets the MLCK/MLC2 pathway in human kidney HK-2 cells

3.Lu Z#, Wang H#, Ishfaq M, Han Y, Zhang X, Li X, Wang B, Lu X, Gao B. Quercetin and AMPK: A Dynamic Duo in Alleviating MG-Induced Inflammation via the AMPK/SIRT1/NF-κB Pathway.

4. Lu Z#, Wang H#, Zhang X, Huang X, Jiang S, Li Y, Liu T, Lu X, Gao B. High fat diet induces brain injury and neuronal apoptosis via down-regulating 3-β hydroxycholesterol 24 reductase (DHCR24). molecular docking analyses. Toxicology. 2022, 446: 153083.

5.Li Y, Lu X, Yu Z, Wang H, Gao B. Meta-data analysis of kidney stone disease highlights ATP1A1 involvement in renal crystal formation.

6.Yang B#, Wang H#, Ma Z, Lu C, Li Y, Lu Z, Lu X, Gao B. A Network Pharmacology Study to Uncover the Multiple Molecular Mechanism of the Chinese Patent Medicine Toujiequwen Granules in the Treatment of Corona Virus Disease 2019 (COVID-19).

7.Li Y, Yang B, Wang H, Hu W, Liu T, Lu X, Gao B. CAV1 unveils a novel therapeutic target for nephrolithiasis by modulating CaSR and ER stress.

8.王浩臻,卢琛,马振中等.基于网络药理学分析的中药治疗硬皮病常用药团的分子机制研究